Harvard Bioscience, Inc.
- HBIO
- NASDAQ
- Medical - Instruments & Supplies
- Life Science Instruments
- Cell/Molecular Research Tools
$8.09
Today −2.65%Quote Oct 16, 2026, 08:00 PM UTC
+0.75%over the last month
Max drawdown −5.5%From 1-month high −5.5%3 months +32.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$36.8M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$38.00
+369.7% from here
Floor
$7.88
2.6% below price
Where the price sits
5 analysts
Analyst range, low to high
$6.00$70.00
- Price $8.09
- Resistance $8.34
- Consensus $38.00
Analysts' average target sits about 370% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $22.7M
- Instruments, Equipment, Software, and Accessories$20.3M89.3%
- Service, Maintenance, and Warranty Contracts$2.4M10.7%
Industry
Medical - Instruments & Supplies
Employees
328
Founded
1901